CA
Chetna Amulakhbhai Savani
About Chetna Amulakhbhai Savani
Data last updated:
Chetna Amulakhbhai Savani is a Whole-Time Director at Dryen Pharmaceuticals Private Limited (since 2020). The company operates in Chemicals. Dryen Pharmaceuticals Private Limited reported revenue of ₹3.5 Lakh (FY 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Dryen Pharmaceuticals Private Limited U24230GJ2018PTC104212 | Whole-Time Director | 29 Feb 2020 | 2018 | ₹3.5 Lakh (FY 2021) | Active |
Board colleagues of Chetna Amulakhbhai Savani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Brijesh Kumar Singh | 08246581 | Dryen Pharmaceuticals Private Limited | Whole-Time Director |
| Hiteshkumar Dhirajlal Lapsiwala | 06561452 | Dryen Pharmaceuticals Private Limited | Whole-Time Director |
| Prince Dineshbhai Desai | 08230143 | Dryen Pharmaceuticals Private Limited | Director |
| Yogesh Samar Singh | 08283863 | Dryen Pharmaceuticals Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chetna Amulakhbhai Savani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chetna Amulakhbhai Savani
Chetna Amulakhbhai Savani currently holds 1 directorship: Dryen Pharmaceuticals Private Limited (Whole-Time Director, since 29 Feb 2020, revenue ₹3.5 Lakh (FY 2021)).
Chetna Amulakhbhai Savani was first appointed on 29 Feb 2020 as Whole-Time Director at Dryen Pharmaceuticals Private Limited.
The current boards of Chetna Amulakhbhai Savani's companies include Brijesh Kumar Singh (Dryen Pharmaceuticals Private Limited), Hiteshkumar Dhirajlal Lapsiwala (Dryen Pharmaceuticals Private Limited), Prince Dineshbhai Desai (Dryen Pharmaceuticals Private Limited), Yogesh Samar Singh (Dryen Pharmaceuticals Private Limited).